Abstract
The pathogenesis of interstitial cystitis is currently unknown. One possible etiology is that the transitional epithelium is defective, leading to molecular leaks that initiate the disease complex. This theory was the principle rationale for the employment by us of pentosanpolysulfate (PPS) in the therapy of interstitial cystitis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fritjofsson Å, Fall M, Juhlin R, Persson BE, Ruutu M (1987) Treatment of ulcer and non-ulcer interstitial cystitis with sodium pentosanpolysulfate: a multicentre trial. J Urol 138: 508–512
Gill WG, Jones KW, Ruggiero KJ(1982) Protective effects of heparin and other sulfated glycosaminoglycans on crystal adhesion to injured urothelium. J Urol 127: 152–154
Holm-Bentzen M, Jacobsen F, Nerstrøm B et al. (1987) A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease. J Urol 138: 503–507
Kaufman JE, Anderson K, Parsons CL (1987) Inactivation of anti-adherence effect of the bladder surface glycosaminoglycans as a possible mechanism for carcinogenesis. Urology 30: 255–258
Parsons CL (1982) Prevention of urinary tract infection by the exogenous glycosaminoglycan sodium pentosanpolysulfate. J Urol 127: 167–169
Parsons CL (1986) Successful management of radiation cystitis with sodium pentosanpolysulfate J Urol 136: 813–814
Parsons CL, Greenspan C, Mulholland SG (1975) The primary antibacterial defense mechanism of the bladder. Invest Urol 13: 72–76
Parsons CL, Greenspan C, Moore SW, Mulholland SG (1977) Role of surface mucin in primary antibacterial defense of bladder. Urology 9: 48–52
Parsons CL, Pollen J, Anwar H, Stauffer C, Schmidt J (1980a) Antibacterial activity of bladder surface mucin duplicated in the rabbit bladder by exogenous glycosaminoglycan (sodium pentosanpolysulfate). Infect Immun 27: 876–881
Parsons CL, Stauffer C, Schmidt JD (1980b) Bladder surface glycosaminoglycans: an efficient mechanism of environmental adaptation. Science 208: 605–607
Parsons CL, Stauffer C, Schmidt JD (1981) Impairment of antibacterial effect of bladder surface mucin by protamine sulfate. J Infect Dis 144: 180
Parsons CL, Schmidt JD, Pollen J (1983) Successful treatment of interstitial cystitis with sodium pentosanpolysulfate. J Urol 130: 51–53
Parsons CL, Danielson B, Feldstrom B (1985) Inhibition of sodium urate crystal adherence to bladder surface by polysaccharide. J Urol 134: 614–616
Parsons CL, Stauffer CW, Schmidt JD (1988) Reversible inactivation of bladder surface glycosaminoglycans antibacterial activity by protamine sulfate. Infect Immun 56: 1341–1343
Parsons CL, Boychuk D, Jones S, Hurst R, Callahan H (1990) Bladder surface glycosaminglycans: an epithelia permeability barrier. Invest Urol 143: 140
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag London Limited
About this chapter
Cite this chapter
Parsons, C.L. (1990). Use of Pentosanpolysulfate in the Management of Interstitial Cystitis. In: Hanno, P.M., Staskin, D.R., Krane, R.J., Wein, A.J. (eds) Interstitial Cystitis. Springer, London. https://doi.org/10.1007/978-1-4471-3293-6_20
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3293-6_20
Publisher Name: Springer, London
Print ISBN: 978-1-4471-3295-0
Online ISBN: 978-1-4471-3293-6
eBook Packages: Springer Book Archive